Atea Pharmaceuticals (AVIR) Return on Equity [ROE] (2020 - 2026)
Atea Pharmaceuticals (AVIR) posted Return on Equity [ROE] of -75.50% for Q2 2026, down 40.39 percentage points from -35.11% a year earlier and down 8.91 percentage points from the prior quarter.
Powered by 
Analysis
Atea Pharmaceuticals (AVIR) Return on Equity [ROE] (2020 - 2026) Analysis & Trends
For FY2025, Atea Pharmaceuticals' Return on Equity [ROE] came in at -44.34%, down 10.46 percentage points from FY2024.
- Annual Return on Equity [ROE] has declined for four consecutive years, with a five-year change of -39.94 percentage points (FY2020 to FY2025).
- In prior years, Atea Pharmaceuticals' Return on Equity [ROE] was -33.88% in FY2024 (-11.14 pp), -22.74% in FY2023 (-5.58 pp), -17.16% in FY2022 (-36.43 pp) and 19.27% in FY2021 (+23.66 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] in data going back to Q4 2020.
- On a year-over-year basis, Return on Equity [ROE] has declined in each of the last four quarters, with an average year-over-year change of -15.75 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q4 2021, with a gain of 23.41 percentage points; the weakest was Q2 2026, with a drop of 40.39 percentage points.
- According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -66.59% (Q1 2026), -53.57% (Q4 2025) and -43.23% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Atea Pharmaceuticals | 337.28 Mn | -631.22 Mn | - | -81.99% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -81.99% |
| Jun 30, 2026 | -75.56% |
| Mar 31, 2026 | -66.67% |
| Dec 31, 2025 | -53.59% |
| Sep 30, 2025 | -43.35% |
| Jun 30, 2025 | -35.03% |
| Mar 31, 2025 | -32.75% |
| Dec 31, 2024 | -37.52% |
| Sep 30, 2024 | -37.03% |
| Jun 30, 2024 | -35.88% |
| Mar 31, 2024 | -30.87% |
| Dec 31, 2023 | -23.76% |
| Sep 30, 2023 | -22.06% |
| Jun 30, 2023 | -17.44% |
| Mar 31, 2023 | -17.41% |
| Dec 31, 2022 | -17.89% |
| Sep 30, 2022 | 5.26% |
| Jun 30, 2022 | 2.32% |
| Mar 31, 2022 | 6.96% |
| Dec 31, 2021 | 18.77% |
API Access
Atea Pharmaceuticals Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "AVIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=AVIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();